Cargando…
Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer
Cervical cancer incidence, globally, is second only to malignant breast cancer. The main causative factor is thought to be human papillomavirus (HPV) infection as a result of many sexual partners. Despite radiotherapy, chemotherapy and surgical treatment, the survival rate of patients with advanced...
Autores principales: | Czerniak, Bartosz, Olszewska-Słonina, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909723/ https://www.ncbi.nlm.nih.gov/pubmed/29692656 http://dx.doi.org/10.5114/wo.2018.74386 |
Ejemplares similares
-
Serum Paraoxonase-1 Activity and the Risk of Prostate Cancer Recurrence in Patients Treated with Radiotherapy
por: Jasinski, Milosz, et al.
Publicado: (2022) -
Serum Paraoxonase-1 Activity in Prostate Cancer Patients Treated with Brachytherapy as a Measure of Irradiation Efficacy
por: Olszewska-Słonina, Dorota, et al.
Publicado: (2023) -
Sperm cyropreservation and oxidative damage. What does it mean?
por: Olszewska–Slonina, Dorota
Publicado: (2013) -
Evaluation of selected parameters of oxidative stress in patients with androgenetic alopecia
por: Cwynar, Anna, et al.
Publicado: (2021) -
Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers
por: Cho, Uiju, et al.
Publicado: (2016)